Sclerosing Mesenteritis
- 1 March 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 146 (3), 503-505
- https://doi.org/10.1001/archinte.1986.00360150113013
Abstract
• We present two patients with an aggressive form of sclerosing mesenteritis characterized by (1) a progressive, lifethreatening course, (2) prominent retroperitoneal disease, and (3) tubuloreticular structures in one case, an ultrastructural feature associated with autoimmune and cyclophosphamideresponsive diseases. In both patients, aggressive immunosuppressive medical therapy with cyclophosphamide resulted in prompt, dramatic improvement, without recurrence. When the diagnosis of sclerosing mesenteritis is established, we recommend early aggressive medical therapy with cyclophosphamide, particularly when tubuloreticular structures are present. (Arch Intern Med 1986;146:503-505)This publication has 5 references indexed in Scilit:
- Endothelial Cell Damage and Tubuloreticular Structures in Interstitial Lung Disease Associated with Collagen Vascular Disease and Viral Pneumonia1–3American Review of Respiratory Disease, 1983
- Human Lupus Inclusions and InterferonScience, 1981
- Sclerosing Mesenteritis: Report of Two CasesAmerican Journal of Clinical Pathology, 1975
- THE ROENTGEN DIAGNOSIS OF RETRACTILE MESENTERITISAmerican Journal of Roentgenology, 1969
- Idiopathic Retroperitoneal Fibrosis Producing Vena Caval, Biliary, Ureteral and Duodenal ObstructionsAnnals of Surgery, 1964